Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 859,888 |
|
|||||
| News | - | ||||||
| Day High | 9.55 | Low High |
|||||
| Day Low | 9.34 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Amicus Therapeutics Inc | FOLD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.09 | -0.95% | 9.41 | 14:39:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.49 | 9.34 | 9.55 | 9.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,085 | 859,888 | $ 9.45 | $ 8,127,296 | - | 9.02 - 14.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:40:13 | 1 | $ 9.405 | USD |
Amicus Therapeutics (FOLD) Options Flow Summary
Amicus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.78B | 295.38M | - | 399.36M | -151.58M | -0.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Amicus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FOLD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.50 | 9.795 | 9.02 | 9.34 | 2,934,553 | -0.09 | -0.95% |
| 1 Month | 10.27 | 10.93 | 9.02 | 10.06 | 3,008,088 | -0.86 | -8.37% |
| 3 Months | 13.48 | 14.02 | 9.02 | 11.40 | 3,131,767 | -4.07 | -30.19% |
| 6 Months | 10.70 | 14.57 | 9.02 | 12.06 | 3,057,638 | -1.29 | -12.06% |
| 1 Year | 10.74 | 14.57 | 9.02 | 12.12 | 2,765,886 | -1.33 | -12.38% |
| 3 Years | 9.40 | 14.57 | 5.91 | 10.93 | 2,715,801 | 0.01 | 0.11% |
| 5 Years | 12.44 | 25.39 | 5.91 | 11.56 | 2,745,787 | -3.03 | -24.36% |
Amicus Therapeutics Description
| Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. |
